摘要:
A method for the detection and multiple, simultaneous quantification of any combination of Listeria sp., Staphylococcus aureus, Campylobacter jejuni and/or Escherichia coli O157.-H7, in one or more test samples, by multiplex amplification reaction, using real-time polymerase chain reaction (PCR). The steps in the method are: (a) extracting DNA from the test sample or samples; (b) preparing a reaction mixture specific for the pathogens to be detected and quantified, such that the reaction mixture contains the necessary reagents for enzymatic amplification of the extracted DNA and identification of the pathogens to be detected and quantified; (c) amplifying the reaction mixture by means of multiplex amplification reaction using PCR; and (d) simultaneously determining the presence or absence of and quantification of the pathogens in the test sample or samples. The method has the special feature that (i) the reaction mixture for enzymatic amplification of the DNA has sets of pairs of oligonucleotide primers identified as SEQ ID No. 1 and SEQ ID No. 2, SEQ ID No. 4 and SEQ ID No. 5, SEQ ID No. 7 and SEQ ID No. 8, and SEQ ID No. 10 and SEQ ID No. 11, and probes with oligonucleotide sequences identified as SEQ ID No. 3, SEQ ID No. 6, SEQ ID No. 9 and SEQ ID No. 12; (ii) the presence or absence of and quantification of said pathogens in any combination is determined by means of a fluorescent signal or fluorescence emission specific for each pathogen.
摘要翻译:一种用于通过多重扩增反应在一个或多个测试样品中检测和多重同时定量任何组合的利斯特氏菌属,金黄色葡萄球菌,空肠弯曲杆菌和/或大肠杆菌O157.-H7的方法,使用实时聚合酶 连锁反应(PCR)。 该方法的步骤是:(a)从测试样品或样品中提取DNA; (b)制备对待检测和定量的病原体特异性的反应混合物,使得反应混合物含有用于酶扩增提取的DNA的必需试剂和待检测和定量的病原体的鉴定; (c)通过使用PCR的多重扩增反应扩增反应混合物; 和(d)同时确定测试样品或样品中病原体的存在或不存在和定量。 该方法具有以下特征:(i)用于DNA扩增的反应混合物具有鉴定为SEQ ID No.1和SEQ ID No.2,SEQ ID No.4和SEQ ID No.的寡核苷酸引物对。 5,SEQ ID No.7和SEQ ID No.8,以及SEQ ID No.10和SEQ ID No.11的寡核苷酸序列的探针,以及鉴定为SEQ ID No.3,SEQ ID No.6,SEQ ID No. 9和SEQ ID No.12; (ii)任何组合中所述病原体的存在或不存在和定量是通过对每种病原体特异性的荧光信号或荧光发射来确定的。
摘要:
A bacterial strain of human origin belonging to the species Bifidobacterium animalis identified as PTA-9175 which produces between 120 ng/ml to 398 ng/ml of folic acid and which can be used as a probiotic in food compositions. The Bifidobacterium animalis strain is deposited with the American Type Culture Collection (ATCC) in the United States of America, under the Budapest Treaty, dated on Apr. 23, 2008, and respectively identified with the ATCC deposit designation number for patent as PTA-9175.
摘要:
A method for multiple and simultaneously detecting and quantifying of Listeria spp, Staphylococcus aureus, Campylobacter jejuni, and Escherichia coli 0157:H7, by extracting DNA from a sample; preparing a reaction mixture for enzymatic amplification of the extracted DNA and sets of pairs of oligonucleotide primers identified as SEQ ID No. 1 and SEQ ID No. 2, SEQ ID No. 4 and SEQ ID No. 5, SEQ ID No. 7 and SEQ ID No. 8, and SEQ ID No. 10 and SEQ ID No. 11, and probes with oligonucleotide sequences identified as SEQ ID No. 3, SEQ ID No. 6, SEQ ID No. 9 and SEQ ID No. 12; providing a thermostable DNA polymerase and magnesium salt to the reaction mixture; amplifying the reaction mixture by a PCR reaction; and determining the presence or absence, and quantification of the pathogens by using a fluorescent signal or fluorescence emission specific for each pathogen.
摘要翻译:通过从样品中提取DNA多次同时检测和定量李斯特氏菌属,金黄色葡萄球菌,空肠弯曲杆菌和大肠杆菌0157:H7的方法; 制备用于提取的DNA的酶促扩增的反应混合物和鉴定为SEQ ID No.1和SEQ ID No.2,SEQ ID No.4和SEQ ID No.5,SEQ ID No.7的寡核苷酸引物对和 SEQ ID No.8和SEQ ID No.10和SEQ ID No.11的寡核苷酸序列的探针,以及鉴定为SEQ ID No.3,SEQ ID No.6,SEQ ID No.9和SEQ ID No.12的寡核苷酸序列的探针。 向反应混合物中提供热稳定的DNA聚合酶和镁盐; 通过PCR反应扩增反应混合物; 并通过使用针对每种病原体的荧光信号或荧光发射来确定病原体的存在或不存在以及定量。
摘要:
A composition for promoting control of total and LDL cholesterol and/or weight loss and/or thermogenesis in individuals, the composition including green tea extract in a quantity of about 200 mg to about 300 mg; guarana extract in a quantity of about 160 mg to about 260 mg; yerba mate extract in a quantity of about 100 mg to about 300 mg; and conjugated linoleic acid in a quantity of about 700 mg to 3400 mg. Additionally, the green tea extract is standardized in a content of at least 50% epigallocatechin gallate (EGCG), while the conjugated linoleic acid is standardized in a content of at least 50% of trans10, cis 12-CLA (10-12 CLA), and 50% cis9, trans11-CLA (9-11 CLA).